Source: BioPortfolio

Selexys Pharmaceuticals: Selexys Pharmaceuticals Corp Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummarySelexys Pharmaceuticals Corp Selexys Pharmaceuticals is a biopharmaceutical company that develops drugs for the treatment of inflammatory and thrombotic diseases. The company's products comprise AntiPselectin which blocks selectin function and preve...

Read full article »
Selexys Pharmaceuticals's Competitors | Selexys Pharmaceuticals's News | Selexys Pharmaceuticals's Financials
Stay up-to-date with the latest news on Selexys Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Scott Rollins's photo - President & CEO of Selexys Pharmaceuticals

President & CEO

Scott Rollins

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Selexys Pharmaceuticals